HS
CRIS icon

HighVista Strategies’s Curis CRIS Stock Holding History

HighVista Strategies’s Portfolio CRIS Stock Details CRIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-431
Closed -$1.35M – 79
2021
Q3 		$1.35M Buy
431
+286
+197% +$893K 0.89% 26
2021
Q2 		$467K Sell
145
-39
-21% -$176K 0.33% 69
2021
Q1 		$835K Buy
+184
New +$770K 0.62% 27

Other funds holding CRIS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

HighVista Strategies's CRIS Position: Q4 2021 in Review

HighVista Strategies sold out of Curis (CRIS) in Q4 2021, closing a stake of 431 shares — an estimated $1.35M sold.

HighVista Strategies first reported a position in CRIS in Q1 2021 and held it in 3 quarters. The position peaked at $1.35M in Q3 2021. 128 funds tracked by Wall St. Rank hold CRIS as of Q4 2021.

  • HighVista Strategies reported no remaining Curis position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 431 Curis shares in Q4 2021, an estimated $1.35M.
  • HighVista Strategies first reported a position in Curis in Q1 2021 and held it in 3 quarters.
  • HighVista Strategies's Curis position peaked at $1.35M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Curis as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.